StonvexLoading…
StonvexStonvexStonvexCore line items from VYX's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2024 2024-09-30 | Annual 2024 2024-06-30 |
|---|---|---|---|---|
Revenue | $2.69B | $2.82B | $711.00M | $722.00M |
Operating Income | $26.00M | $-38.00M | $15.00M | $-35.00M |
Net Income | $62.00M | $958.00M | $1.08B | $-73.00M |
EPS (Diluted) | $0.30 | $6.52 | $7.41 | $-0.53 |
Total Assets | $3.92B | $4.45B | Not available | Not available |
Total Liabilities | $2.77B | $3.25B | Not available | Not available |
Cash & Equivalents | $231.00M | $722.00M | Not available | Not available |
Free Cash Flow OCF − CapEx | $-375.00M | $-162.00M | Not available | Not available |
Shares Outstanding | 138.30M | 142.10M | Not available | Not available |